150 related articles for article (PubMed ID: 36897780)
21. Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.
ElMokh O; Matsumoto S; Biniecka P; Bellotti A; Schaeuble K; Piacente F; Gallart-Ayala H; Ivanisevic J; Stamenkovic I; Nencioni A; Nahimana A; Duchosal MA
Cell Death Dis; 2022 Apr; 13(4):320. PubMed ID: 35396381
[TBL] [Abstract][Full Text] [Related]
22. PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection.
Tran MT; Zsengeller ZK; Berg AH; Khankin EV; Bhasin MK; Kim W; Clish CB; Stillman IE; Karumanchi SA; Rhee EP; Parikh SM
Nature; 2016 Mar; 531(7595):528-32. PubMed ID: 26982719
[TBL] [Abstract][Full Text] [Related]
23. Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process.
Khaidizar FD; Bessho Y; Nakahata Y
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918226
[TBL] [Abstract][Full Text] [Related]
24. Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes.
Yang SJ; Choi JM; Kim L; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
J Nutr Biochem; 2014 Jan; 25(1):66-72. PubMed ID: 24314867
[TBL] [Abstract][Full Text] [Related]
25. Perturbations of NAD
Agerholm M; Dall M; Jensen BAH; Prats C; Madsen S; Basse AL; Graae AS; Risis S; Goldenbaum J; Quistorff B; Larsen S; Vienberg SG; Treebak JT
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E377-E395. PubMed ID: 29208611
[TBL] [Abstract][Full Text] [Related]
26. Loss of NAMPT in aging retinal pigment epithelium reduces NAD
Jadeja RN; Powell FL; Jones MA; Fuller J; Joseph E; Thounaojam MC; Bartoli M; Martin PM
Aging (Albany NY); 2018 Jun; 10(6):1306-1323. PubMed ID: 29905535
[TBL] [Abstract][Full Text] [Related]
27. Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes.
Hsu CP; Hariharan N; Alcendor RR; Oka S; Sadoshima J
Autophagy; 2009 Nov; 5(8):1229-31. PubMed ID: 19855187
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a Potent Nicotinamide Phosphoribosyltransferase Activator for Improving Aging-associated Dysfunctions.
Yang S; Sun D; Wu Y; Chen S; Guo Y; Li J; Dong G; Sheng C
J Med Chem; 2024 Mar; 67(5):4120-4130. PubMed ID: 38367219
[TBL] [Abstract][Full Text] [Related]
29. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.
Hsu CP; Oka S; Shao D; Hariharan N; Sadoshima J
Circ Res; 2009 Aug; 105(5):481-91. PubMed ID: 19661458
[TBL] [Abstract][Full Text] [Related]
30. Boosting NAD
Gardell SJ; Hopf M; Khan A; Dispagna M; Hampton Sessions E; Falter R; Kapoor N; Brooks J; Culver J; Petucci C; Ma CT; Cohen SE; Tanaka J; Burgos ES; Hirschi JS; Smith SR; Sergienko E; Pinkerton AB
Nat Commun; 2019 Jul; 10(1):3241. PubMed ID: 31324777
[TBL] [Abstract][Full Text] [Related]
31. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
32. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD
Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; Calabrò M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S
J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable.
Xiao Y; Kwong M; Daemen A; Belvin M; Liang X; Hatzivassiliou G; O'Brien T
PLoS One; 2016; 11(10):e0164166. PubMed ID: 27711204
[TBL] [Abstract][Full Text] [Related]
34. Comparison of metabolic fates of nicotinamide, NAD+ and NADH administered orally and intraperitoneally; characterization of oral NADH.
Kimura N; Fukuwatari T; Sasaki R; Shibata K
J Nutr Sci Vitaminol (Tokyo); 2006 Apr; 52(2):142-8. PubMed ID: 16802695
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
[TBL] [Abstract][Full Text] [Related]
36. Discovery of a novel nicotinamide phosphoribosyl transferase (NAMPT) inhibitor via in silico screening.
Takeuchi M; Niimi T; Masumoto M; Orita M; Yokota H; Yamamoto T
Biol Pharm Bull; 2014; 37(1):31-6. PubMed ID: 24389478
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of NAD
Ghanem MS; Caffa I; Monacelli F; Nencioni A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396769
[TBL] [Abstract][Full Text] [Related]
38. Subcellular NAMPT-mediated NAD
Wang X; Zhang Z; Zhang N; Li H; Zhang L; Baines CP; Ding S
J Neurochem; 2019 Dec; 151(6):732-748. PubMed ID: 31553812
[TBL] [Abstract][Full Text] [Related]
39. Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators.
Pinkerton AB; Sessions EH; Hershberger P; Maloney PR; Peddibhotla S; Hopf M; Sergienko E; Ma CT; Smith LH; Jackson MR; Tanaka J; Tsuji T; Akiu M; Cohen SE; Nakamura T; Gardell SJ
Bioorg Med Chem Lett; 2021 Jun; 41():128007. PubMed ID: 33798699
[TBL] [Abstract][Full Text] [Related]
40. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.
Imai S
Curr Pharm Des; 2009; 15(1):20-8. PubMed ID: 19149599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]